Details for New Drug Application (NDA): 204764
✉ Email this page to a colleague
The generic ingredient in LINEZOLID is linezolid. There are twenty-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the linezolid profile page.
Summary for 204764
Tradename: | LINEZOLID |
Applicant: | Fresenius Kabi Usa |
Ingredient: | linezolid |
Patents: | 0 |
Suppliers and Packaging for NDA: 204764
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LINEZOLID | linezolid | SOLUTION;INTRAVENOUS | 204764 | ANDA | Fresenius Kabi USA, LLC | 63323-713 | 63323-713-13 | 10 BAG in 1 CASE (63323-713-13) / 300 mL in 1 BAG (63323-713-03) |
LINEZOLID | linezolid | SOLUTION;INTRAVENOUS | 204764 | ANDA | Hp Halden Pharma AS | 66298-7131 | 66298-7131-3 | 300 mL in 1 BAG (66298-7131-3) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 600MG/300ML (2MG/ML) | ||||
Approval Date: | Mar 15, 2016 | TE: | AP | RLD: | No |
Complete Access Available with Subscription